Cargando…
Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients
Isoniazid (INH), recommended by WHO (World Health Organization) in the treatment of tuberculosis (TB), is metabolized primarily by the genetically polymorphic N-acetyltransferase 2 (NAT2) enzyme. The human population is divided into three different phenotypic groups according to acetylation rate: sl...
Autores principales: | Toure, A., Cabral, M., Niang, A., Diop, C., Garat, A., Humbert, L., Fall, M., Diouf, A., Broly, F., Lhermitte, M., Allorge, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616082/ https://www.ncbi.nlm.nih.gov/pubmed/28959610 http://dx.doi.org/10.1016/j.toxrep.2016.10.004 |
Ejemplares similares
-
NAT2 Genotype and Isoniazid Medication in Children
por: Golka, Klaus, et al.
Publicado: (2016) -
The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern Thailand
por: Ungcharoen, Usanee, et al.
Publicado: (2020) -
Chronic dialysis, NAT2 polymorphisms, and the risk of isoniazid-induced encephalopathy – case report and literature review
por: Constantinescu, Stefan Matei, et al.
Publicado: (2017) -
Scleroderma renal crisis in tropical region: two senegalese cases
por: Cisse, Mouhamadou Moustapha, et al.
Publicado: (2015) -
Frequencies and Distribution of APOE Gene Polymorphisms and Its Association With Lipid Parameters in the Senegalese Population
por: Touré, Maïmouna, et al.
Publicado: (2022)